These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33120945)

  • 21. Nanotechnology as a potential therapeutic alternative for schistosomiasis.
    Tomiotto-Pellissier F; Miranda-Sapla MM; Machado LF; Bortoleti BTDS; Sahd CS; Chagas AF; Assolini JP; Oliveira FJA; Pavanelli WR; Conchon-Costa I; Costa IN; Melanda FN
    Acta Trop; 2017 Oct; 174():64-71. PubMed ID: 28668252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
    Kanapathipillai M; Brock A; Ingber DE
    Adv Drug Deliv Rev; 2014 Dec; 79-80():107-18. PubMed ID: 24819216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology advances in brain tumors: the state of the art.
    Invernici G; Cristini S; Alessandri G; Navone SE; Canzi L; Tavian D; Redaelli C; Acerbi F; Parati EA
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):58-69. PubMed ID: 21110824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Nanotherapies for the Treatment of Surgical Diseases.
    Morgan CE; Wasserman MA; Kibbe MR
    Ann Surg; 2016 May; 263(5):900-7. PubMed ID: 26756763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma.
    Samie HAA; Saeed M; Faisal SM; Kausar MA; Kamal MA
    Curr Drug Metab; 2019; 20(4):283-291. PubMed ID: 30854953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.
    Uppal S; Italiya KS; Chitkara D; Mittal A
    Acta Biomater; 2018 Nov; 81():20-42. PubMed ID: 30268916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.
    de la Puente P; Azab AK
    Eur J Haematol; 2017 Jun; 98(6):529-541. PubMed ID: 28208215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer.
    Caster JM; Wang AZ
    Ther Deliv; 2017 Aug; 8(9):791-803. PubMed ID: 28825397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional Nanotherapeutics with All-in-One Nanoentrapment of Drug/Gene/Inorganic Nanoparticle.
    Jia HZ; Wang W; Zheng DW; Wang X; Yu WY; Li SY; Zhuo RX; Zhao YF; Feng J; Zhang XZ
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6784-9. PubMed ID: 26962876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy.
    Safdar MH; Hussain Z; Abourehab MAS; Hasan H; Afzal S; Thu HE
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1967-1980. PubMed ID: 29082766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facile route to versatile nanoplatforms for drug delivery by one-pot self-assembly.
    Zhou X; Che L; Wei Y; Dou Y; Chen S; He H; Gong H; Li X; Zhang J
    Acta Biomater; 2014 Jun; 10(6):2630-42. PubMed ID: 24486911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.
    Eifler AC; Thaxton CS
    Methods Mol Biol; 2011; 726():325-38. PubMed ID: 21424459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in Nanoparticles as Anticancer Drug Delivery Vector: Need of this Century.
    Ali I; Mukhtar SD; Ali HS; Scotti MT; Scotti L
    Curr Pharm Des; 2020; 26(15):1637-1649. PubMed ID: 32013826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension.
    Segura-Ibarra V; Wu S; Hassan N; Moran-Guerrero JA; Ferrari M; Guha A; Karmouty-Quintana H; Blanco E
    Front Physiol; 2018; 9():890. PubMed ID: 30061840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle-Based Drug Delivery Systems for Enhanced Tumor-Targeting Treatment.
    Li Y; Zhang H
    J Biomed Nanotechnol; 2019 Jan; 15(1):1-27. PubMed ID: 30480512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil-Based Delivery Systems for Nanotherapeutics.
    Han Y; Zhao R; Xu F
    Small; 2018 Oct; 14(42):e1801674. PubMed ID: 30144279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil-mediated delivery of nanotherapeutics across blood vessel barrier.
    Dong X; Chu D; Wang Z
    Ther Deliv; 2018 Jan; 9(1):29-35. PubMed ID: 29216803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer.
    Singh P; Pandit S; Mokkapati VRSS; Garg A; Ravikumar V; Mijakovic I
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.